ClinicalTrials.Veeva

Menu

New-DES vs BMS in SVG -1 Year Outcomes (BALTIC)

M

Medical University of Silesia

Status

Completed

Conditions

Coronary Artery Disease

Treatments

Device: new-DES
Device: BMS

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Data regarding the efficacy of the percutaneous coronary intervention (PCI) with new-designed drug-eluting stent (new-DES) vs. bare metal stent (BMS) of saphenous vein grafts (SVG) stenosis is scarce. The primary objective was to compare one-year clinical outcomes of PCI in stenosis of SVG using new-DES vs. BMS in a real-world population. We carried out a multi-center registry comparing new-DES with BMS in all consecutive patients undergoing PCI of SVG. The primary composite endpoint was major adverse cardiac and cerebrovascular events (MACCE) at 1 year.

Enrollment

792 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients after CABG with significant SVG stenosis referred for PCI

Exclusion criteria

  • patients who had both types of stents implanted in the same procedure
  • patients with the old-DES
  • patients who had PCI of other vascular territories during the same procedure

Trial design

792 participants in 1 patient group

SVG PCI
Treatment:
Device: new-DES
Device: BMS

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems